N-acetyl-l-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway-Reference-Cited by-同舟云学术

N-acetyl-l-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway

Published:2014-09 Issue:7 Volume:68 Page:855-864
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Qanungo Suparna,Uys Joachim D.,Manevich Yefim,Distler Anne M.,Shaner Brooke,Hill Elizabeth G.,Mieyal John J.,Lemasters John J.,Townsend Danyelle M.,Nieminen Anna-Liisa

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2013

2. Defining new paradigms for the treatment of pancreatic cancer;Almhanna;Curr Treat Options Oncol,2011

3. Costs and trends in pancreatic cancer treatment;O’Neill;Cancer,2012

4. Pancreatic cancer;Chrystoja;Clin Chem,2013

5. Treatment options for advanced pancreatic cancer: a review;Warsame;Expert Rev Anticancer Ther,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-translational modifications of p65: state of the art;Frontiers in Cell and Developmental Biology;2024-07-10

2. A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines;Frontiers in Pharmacology;2024-03-20

3. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells;Bioorganic Chemistry;2024-01

4. Nuclear factor kappa B expression in non-small cell lung cancer;Biomedicine & Pharmacotherapy;2023-11

5. NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells;Redox Biology;2022-11